SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,939.60 |
| Enterprise Value ($M) | 1,685.87 |
| Book Value ($M) | 1,626.67 |
| Book Value / Share | 28.52 |
| Price / Book | 1.19 |
| NCAV ($M) | 909.07 |
| NCAV / Share | 15.94 |
| Price / NCAV | 2.13 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.40 |
| Return on Assets (ROA) | 0.72 |
| Return on Equity (ROE) | 0.83 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.77 |
| Current Ratio | 8.99 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,074.19 |
| Assets | 1,791.79 |
| Liabilities | 165.12 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Farallon Capital Partners, L.P. | |||
| 13G/A | Armistice Capital, Llc | 3.88 | -37.37 | |
| 13G/A | Rock Springs Capital Management LP | 3.85 | -28.18 | |
| 13G/A | Bb Biotech Ag | 7.20 | -0.76 | |
| 13G/A | Vanguard Group Inc | 9.89 | 3.61 | |
| 13G/A | BlackRock, Inc. | 8.90 | 4.05 | |
| 13G/A | State Street Corp | 4.70 | -17.41 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 52,382 | 392,513 | 13.35 | |
| 48,063 | 333,682 | 14.40 | |
| 72,005 | 424,917 | 16.95 | |
| 119,531 | 462,096 | 25.87 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ACRS – Aclaris Therapeutics, Inc. | ACT – Enact Holdings, Inc. |
| ADPT – Adaptive Biotechnologies Corporation | AKRO – Akero Therapeutics, Inc. |
| ALEC – Alector, Inc. |
Financial data and stock pages provided by
Fintel.io